Federico Perosa

full professor

University of Bari Aldo Moro

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Federico Perosa is a full professor at the University of Bari Aldo Moro in Italy. His research focuses on adult-onset Still's disease, systemic juvenile idiopathic arthritis, and the clinical impacts of biologic treatments. Recent publications explore the prognosis of adult-onset Still's disease, disparities in clinical features, and the inflammatory syndrome associated with SARS-CoV-2. He is actively engaged in understanding the complexities of autoimmune diseases and their treatment outcomes.

Articles (8)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Francesco Caso

Assistant Professor

Azienda Ospedaliero-Universitaria Maggiore della Carità

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Federico Perosa

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.

An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis.

Adult-onset Still's disease with elderly onset: results from a multicentre study.

HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis

Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces.

SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment

Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort

Collaborators (1)

Francesco Caso

Make your next move.